Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

  • 1, 15Email author,
  • 2, 14,
  • 3,
  • 4,
  • 5,
  • 5,
  • 5,
  • 6,
  • 6,
  • 1,
  • 1,
  • 1, 7,
  • 3,
  • 13,
  • 3,
  • 8,
  • 9, 10,
  • 11,
  • 3,
  • 3,
  • 8,
  • 7, 12, 14,
  • 8, 12,
  • 2, 13, 14,
  • 4,
  • 5,
  • 11, 12,
  • 1 and
  • 1, 3Email author
Contributed equally
Genome Biology201718:46

https://doi.org/10.1186/s13059-017-1180-8

  • Received: 23 February 2017
  • Accepted: 23 February 2017
  • Published:

The original article was published in Genome Biology 2016 17:231

Erratum

After publication of this article [1] we noticed that authors Yasin Şenbabaoğlu and Ron S. Gejman were omitted as equal contributors. This has now been corrected in the author list.

The publisher apologises for these errors.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Computational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(2)
Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(3)
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(4)
Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(5)
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
(6)
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(7)
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(8)
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(9)
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
(10)
Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia
(11)
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(12)
Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(13)
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
(14)
Weill Cornell Medical College, New York, NY, USA
(15)
Present address: Swim Across America/Ludwig Collaborative Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Reference

  1. Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biology. 2016;17:231.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

Advertisement